ProBase

10/18/2023 - "Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial."
01/01/2023 - "PROBASE is a population-based, randomized trial of 46 495 German men recruited at age 45 to compare effects of risk-adapted prostate cancer (PCa) screening starting either immediately at age 45, or at a deferred age of 50 years. "
01/01/2023 - "Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial."
01/01/2022 - "A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial."
05/01/2021 - "Based on the experience of various international screening studies, the German Prostate Cancer Early Detection Study Based on a Baseline PSA Value in Young Men (PROBASE) was established in 2014. "

05/01/2021 - "Aus den Erfahrungen verschiedener internationaler Screeningstudien wurde 2014 die deutsche „Prostate Cancer Early Detection Study Based on a Baseline PSA Value in Young Men“ (PROBASE) etabliert. "

10/01/2016 - "[Self-concept and erectile dysfunction in 45-year-old men : Results of a corollary study of the PROBASE trial]."

08/18/2023 - "Five 3D-printed (NextDent Ortho Rigid, Dental LT Clear, Dentona Flexisplint, Cosmos Bite Splint, and ProArt Print Splint), one milled (ProArt CAD Splint), and one cold-polymerized (ProBase Cold) occlusal splint materials were used to determine flexural strength and surface hardness values. "